Organoclick Financials
| ORGC Stock | SEK 2.23 0.05 2.19% |
Organoclick |
Please note, the imprecision that can be found in Organoclick's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Organoclick AB. Check Organoclick's Beneish M Score to see the likelihood of Organoclick's management manipulating its earnings.
Organoclick Stock Summary
Organoclick competes with Eolus Vind, Zaptec AS, NOTE AB, GomSpace Group, and Cadeler As. OrganoClick AB develops, produces, and markets functional materials in Sweden. OrganoClick AB was founded in 2006 and is headquartered in Tby, Sweden. OrganoClick operates under Research And Specialist Materials classification in Sweden and is traded on Stockholm Stock Exchange.| Foreign Associate | USA |
| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0006510335 |
| Business Address | LinjalvAegen 9, Tby, |
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| Benchmark | Dow Jones Industrial |
| Website | www.organoclick.com |
| Phone | 46 86 74 00 80 |
| Currency | SEK - Swedish Kronor |
You should never invest in Organoclick without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Organoclick Stock, because this is throwing your money away. Analyzing the key information contained in Organoclick's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Organoclick Key Financial Ratios
Organoclick's financial ratios allow both analysts and investors to convert raw data from Organoclick's financial statements into concise, actionable information that can be used to evaluate the performance of Organoclick over time and compare it to other companies across industries.Organoclick Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Organoclick's current stock value. Our valuation model uses many indicators to compare Organoclick value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Organoclick competition to find correlations between indicators driving Organoclick's intrinsic value. More Info.Organoclick AB is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Organoclick's earnings, one of the primary drivers of an investment's value.Organoclick AB Systematic Risk
Organoclick's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Organoclick volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Organoclick AB correlated with the market. If Beta is less than 0 Organoclick generally moves in the opposite direction as compared to the market. If Organoclick Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Organoclick AB is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Organoclick is generally in the same direction as the market. If Beta > 1 Organoclick moves generally in the same direction as, but more than the movement of the benchmark.
Organoclick March 21, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Organoclick help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Organoclick AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Organoclick AB based on widely used predictive technical indicators. In general, we focus on analyzing Organoclick Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Organoclick's daily price indicators and compare them against related drivers.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 19.93 | |||
| Value At Risk | (4.00) | |||
| Potential Upside | 5.86 |
Additional Tools for Organoclick Stock Analysis
When running Organoclick's price analysis, check to measure Organoclick's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Organoclick is operating at the current time. Most of Organoclick's value examination focuses on studying past and present price action to predict the probability of Organoclick's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Organoclick's price. Additionally, you may evaluate how the addition of Organoclick to your portfolios can decrease your overall portfolio volatility.